BIOHORIZONS INC.

Manufacturer adverse-event records for BIOHORIZONS INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2018–2026 · heavy-book · quiet Death-code · injury-heavy

Death-code intensity

BIOHORIZONS INC. is quieter on Death-coded events

Death-coded event_type rows are 0 of 52,786 (0.00% · quiet tercile among 434 manufacturers). Absolute volume is heavy-book.

What the Death-code reading shows for BIOHORIZONS INC.

The standout signal for BIOHORIZONS INC. is Death-code intensity: 0.00% of 52,786 reports (quiet tercile), while absolute volume is heavy-book.

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair BIOHORIZONS INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 3 device types, led in this extract by Injury at 52,765 (100.0% of event_type total). Peak single-year volume reaches 20,033 reports across 4 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

52,786
Total Reports
0
Event-type Death
52,765
Injury Reports
3
Device Types

Event Types

Injury 52,765 (100.0%)
Malfunction 21 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 51,832 (99.9%)
R 28 (0.1%)
1 (0.0%)

Yearly Trend

18
2018: 1
24
2024: 18,220
25
2025: 20,033
26
2026: 14,532